Reynders McVeigh Capital Management LLC Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

Reynders McVeigh Capital Management LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 99,959 shares of the company's stock, valued at approximately $1,784,000. Reynders McVeigh Capital Management LLC owned about 0.30% of Grail at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Crcm LP bought a new position in Grail in the 4th quarter worth approximately $65,061,000. Primecap Management Co. CA bought a new position in shares of Grail in the fourth quarter worth $37,118,000. Vanguard Group Inc. acquired a new position in shares of Grail during the fourth quarter valued at $25,902,000. Arbiter Partners Capital Management LLC bought a new stake in shares of Grail during the fourth quarter valued at about $14,827,000. Finally, Geode Capital Management LLC acquired a new stake in Grail in the fourth quarter worth about $7,920,000.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

Insider Activity at Grail

In other news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares in the company, valued at $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares of the company's stock, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,550 shares of company stock worth $360,436.

Grail Price Performance

Shares of NASDAQ:GRAL traded up $0.50 on Friday, reaching $27.00. 642,745 shares of the company traded hands, compared to its average volume of 1,221,381. The company's 50 day moving average is $32.95 and its 200-day moving average is $23.48. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, equities analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.